Login / Signup

Clinical Decision Support System with Renal Dose Adjustment Did Not Improve Subsequent Renal and Hepatic Function among Inpatients: The Japan Adverse Drug Event Study.

Ryuhei WadaJiro TakeuchiTsukasa NakamuraTomohiro SonoyamaShinji KosakaChisa MatsumotoMio SakumaYoshinori OhtaTakeshi Morimoto
Published in: Applied clinical informatics (2020)
The CDSS implementation did not affect the incidence of renal and HD and changes in renal and hepatic function among hospitalized patients. The effectiveness of the CDSS with renal-guided doses should be investigated with respect to other endpoints.
Keyphrases
  • clinical decision support
  • adverse drug
  • healthcare
  • randomized controlled trial
  • systematic review
  • primary care
  • emergency department
  • risk factors
  • high resolution
  • quality improvement
  • drug induced